University of Minnesota. Driven to Discover.
A WHO panel raises concerns about an increase in wild poliovirus cases, among other setbacks.
Ten years after primary vaccination, 73 of 75 participants had seroprotective antibody levels.
Alongside the finding that progress has stalled in hard-hit countries, the WHO and partners launch a new response strategy.
The patient is a Nigeria resident who likely contracted the infection there before traveling to the United Kingdom.
The study provides evidence that population immunity is critical for the successful phase-out of oral polio vaccines.
Researchers described tactics and tools for use in conflict and humanitarian zones and showed threats from cominated blood bank supplies.
Young adult men are hardest hit by the typically rodent-borne disease.
Cases are now at 353, an increase of 140 cases from the previous week.
The positive results shed light on what could be one of the largest monkeypox outbreaks in Africa.
The campaign is targeting 874,000 people in two states, Kwara and Kogi.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.